BIOMAT Database Logo BIOMAT Database Logo

Mutations affecting local anesthetic block of the nicotinic acetylcholine receptor ion channel. 1991

R J Leonard, and P Charnet, and C Labarca, and N J Vogelaar, and L Czyzyk, and A Gouin, and N Davidson, and H A Lester
Department of Biology, California Institute of Technology, Pasadena 91125.

UI MeSH Term Description Entries
D007473 Ion Channels Gated, ion-selective glycoproteins that traverse membranes. The stimulus for ION CHANNEL GATING can be due to a variety of stimuli such as LIGANDS, a TRANSMEMBRANE POTENTIAL DIFFERENCE, mechanical deformation or through INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS. Membrane Channels,Ion Channel,Ionic Channel,Ionic Channels,Membrane Channel,Channel, Ion,Channel, Ionic,Channel, Membrane,Channels, Ion,Channels, Ionic,Channels, Membrane
D008012 Lidocaine A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE. Lignocaine,2-(Diethylamino)-N-(2,6-Dimethylphenyl)Acetamide,2-2EtN-2MePhAcN,Dalcaine,Lidocaine Carbonate,Lidocaine Carbonate (2:1),Lidocaine Hydrocarbonate,Lidocaine Hydrochloride,Lidocaine Monoacetate,Lidocaine Monohydrochloride,Lidocaine Monohydrochloride, Monohydrate,Lidocaine Sulfate (1:1),Octocaine,Xylesthesin,Xylocaine,Xylocitin,Xyloneural
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011978 Receptors, Nicotinic One of the two major classes of cholinergic receptors. Nicotinic receptors were originally distinguished by their preference for NICOTINE over MUSCARINE. They are generally divided into muscle-type and neuronal-type (previously ganglionic) based on pharmacology, and subunit composition of the receptors. Nicotinic Acetylcholine Receptors,Nicotinic Receptors,Nicotinic Acetylcholine Receptor,Nicotinic Receptor,Acetylcholine Receptor, Nicotinic,Acetylcholine Receptors, Nicotinic,Receptor, Nicotinic,Receptor, Nicotinic Acetylcholine,Receptors, Nicotinic Acetylcholine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000779 Anesthetics, Local Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. Anesthetics, Conduction-Blocking,Conduction-Blocking Anesthetics,Local Anesthetic,Anesthetics, Topical,Anesthetic, Local,Anesthetics, Conduction Blocking,Conduction Blocking Anesthetics,Local Anesthetics,Topical Anesthetics
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

R J Leonard, and P Charnet, and C Labarca, and N J Vogelaar, and L Czyzyk, and A Gouin, and N Davidson, and H A Lester
[Ion channel property of the nicotinic acetylcholine receptor].
April 1989, Sheng li ke xue jin zhan [Progress in physiology],
R J Leonard, and P Charnet, and C Labarca, and N J Vogelaar, and L Czyzyk, and A Gouin, and N Davidson, and H A Lester
The nicotinic acetylcholine receptor and its ion channel.
July 1986, European journal of biochemistry,
R J Leonard, and P Charnet, and C Labarca, and N J Vogelaar, and L Czyzyk, and A Gouin, and N Davidson, and H A Lester
Mutations affecting agonist sensitivity of the nicotinic acetylcholine receptor.
September 1991, Biophysical journal,
R J Leonard, and P Charnet, and C Labarca, and N J Vogelaar, and L Czyzyk, and A Gouin, and N Davidson, and H A Lester
N-methylanatoxinol isomers: derivatives of the agonist (+)-anatoxin-a block the nicotinic acetylcholine receptor ion channel.
February 1989, Molecular pharmacology,
R J Leonard, and P Charnet, and C Labarca, and N J Vogelaar, and L Czyzyk, and A Gouin, and N Davidson, and H A Lester
Open channel structure and ion binding sites of the nicotinic acetylcholine receptor channel.
March 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience,
R J Leonard, and P Charnet, and C Labarca, and N J Vogelaar, and L Czyzyk, and A Gouin, and N Davidson, and H A Lester
Triphenylmethylphosphonium is an ion channel ligand of the nicotinic acetylcholine receptor.
April 1982, Proceedings of the National Academy of Sciences of the United States of America,
R J Leonard, and P Charnet, and C Labarca, and N J Vogelaar, and L Czyzyk, and A Gouin, and N Davidson, and H A Lester
[Ion channel topography of the neuronal nicotinic acetylcholine receptor : pharmacochemical approaches].
January 2002, Bioorganicheskaia khimiia,
R J Leonard, and P Charnet, and C Labarca, and N J Vogelaar, and L Czyzyk, and A Gouin, and N Davidson, and H A Lester
A modified nicotinic acetylcholine receptor lacking the 'ion channel amphipathic helices'.
August 1987, FEBS letters,
R J Leonard, and P Charnet, and C Labarca, and N J Vogelaar, and L Czyzyk, and A Gouin, and N Davidson, and H A Lester
Site-specific mutations of nicotinic acetylcholine receptor at the lipid-protein interface dramatically alter ion channel gating.
April 1992, Biophysical journal,
R J Leonard, and P Charnet, and C Labarca, and N J Vogelaar, and L Czyzyk, and A Gouin, and N Davidson, and H A Lester
Alteration in ion channel function of mouse nicotinic acetylcholine receptor by mutations in the M4 transmembrane domain.
July 1999, The Journal of membrane biology,
Copied contents to your clipboard!